申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04591590A1
公开(公告)日:1986-05-27
The present invention relates to novel benzhydrylpiperazine derivatives having anti-allergic activities, the preparation of these derivatives, pharmaceutical compositions comprising the same, and to a method of using these compounds therapeutically in the treatment of allergic symptoms in human beings and animals. These benzhydrylpiperazine derivatives have the follow formula: ##STR1## wherein A is a lower alkylene, Z is a benzhydryl optionally substituted with halogen, and R.sup.1 is amino, aryl, pyridyl, acyl or acylamino, in which the aryl group and pyridyl group are substituted with nitro, amino or acyl amino groups, provided that Z is benzhydryl substituted with a halogen, when R.sup.1 is an amino group.
本发明涉及具有抗过敏活性的新型苯基哌嗪衍生物,这些衍生物的制备,包含这些衍生物的药物组合物,以及在人类和动物的过敏症状治疗中治疗使用这些化合物的方法。这些苯基哌嗪衍生物具有以下结构式:##STR1## 其中A是较低的烷基,Z是苯基哌嗪,可以用卤素取代,R.sup.1是氨基,芳基,吡啶基,酰基或酰氨基,在其中芳基和吡啶基被硝基,氨基或酰氨基取代,假设Z是苯基哌嗪,当R.sup.1是氨基时,Z被卤素取代。